首页> 外国专利> MRNA AND/OR PROTEIN OF ERCC1 ISOFORM 3 FOR USE IN DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT AND METHOD FOR DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT USING SAID MRNA AND/OR PROTEIN

MRNA AND/OR PROTEIN OF ERCC1 ISOFORM 3 FOR USE IN DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT AND METHOD FOR DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT USING SAID MRNA AND/OR PROTEIN

机译:用于使用治疗性试剂诊断耐药性的ERCC1 ISOFORM 3的MRNA和/或蛋白以及使用所述MRNA和/或蛋白诊断治疗试剂抗性的方法

摘要

A method for diagnosing a resistance against a therapeutic agent in a patient, which includes measuring an amount of ERCC1 isoform 3 protein and/or an amount of ERCC1 isoform 3 mRNA, which present in a liquid sample or a tissue sample obtained from the patient, and comparing the measured amount to a predetermined value, wherein an amount above the predetermined value indicates resistance against said therapeutic agent.
机译:一种诊断患者对治疗剂的抗性的方法,该方法包括测量从患者获得的液体样品或组织样品中存在的ERCC1亚型3蛋白和/或ERCC1亚型3 mRNA的量,将测量的量与预定值进行比较,其中高于预定值的量表示对所述治疗剂的抗性。

著录项

  • 公开/公告号EP3194616A1

    专利类型

  • 公开/公告日2017-07-26

    原文格式PDF

  • 申请/专利权人 ADNAGEN GMBH;

    申请/专利号EP20150766784

  • 申请日2015-09-16

  • 分类号C12Q1/68;

  • 国家 EP

  • 入库时间 2022-08-21 14:04:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号